Form 4 for ICUI ICU MEDICAL INC/DE
Accepted 2024-08-16 00:00:00 ET · period of report 2024-08-16 · accession 0001410442-24-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-16 | 2024-08-16 | ICUI | Jain Vivek | COB, CEO, Dir | M - OptEx | $88.76 | +12.0K | 116.6K | +11% | +$1.07M |
| D | 2024-08-16 | 2024-08-16 | ICUI | Jain Vivek | COB, CEO, Dir | S - Sale+OE | $156.04 | -12.0K | 104.6K | -10% | -$1.87M |
| D | 2024-08-16 | 2024-08-16 | ICUI | Jain Vivek | COB, CEO, Dir | M - OptEx | $0.00 | -12.0K | 49.4K | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-16 | M | A | 12,000 | $88.76 | 116,593 | D | — | — | (F1) The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. |
| 2 | Common | Common Stock | 2024-08-16 | S | D | 12,000 | $156.04 | 104,593 | D | — | — | (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. (F3) All shares sold were sold at the exact price disclosed. |
| 3 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-08-16 | M | D | 12,000 | $0.00 | 49,373 | D | $88.76 · 2018-02-11 to 2025-02-11 | 12,000 Common Stock | (F1) The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. |